Key result
Extended continuous EEG beyond 7 days in aSAH yields no diagnostic benefit but lengthens stay.
Why the study?
A standard duration of continuous EEG monitoring to detect seizures and delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage has not been established.
Does longer continuous EEG monitoring improve the detection of complications or functional outcomes in patients with aneurysmal subarachnoid hemorrhage?
Observational (n=35)
No
Does longer continuous EEG monitoring improve the detection of complications or functional outcomes in patients with aneurysmal subarachnoid hemorrhage?
Absolute Event Rate: 81.3% vs 68.4%
p-value: p=0.39
Extending continuous EEG monitoring beyond 6-7 days in aSAH patients does not significantly increase the detection of critical complications or improve functional outcomes, but is associated with unnecessarily prolonged ICU and hospital lengths of stay.
Extended EEG beyond 7 days adds no detection benefit yet prolongs ICU and hospital stay; leaves open optimal duration in aneurysmal subarachnoid hemorrhage.
Background Electroencephalography (EEG) can detect seizures and delayed cerebral ischemia (DCI) in patients with aneurysmal subarachnoid hemorrhage (aSAH). Because a standard duration of continuous EEG monitoring to capture these complications has not been established in aSAH, we compared a standard 6- or 7-day cEEG monitoring protocol versus longer periods of monitoring. Methods We performed a retrospective analysis of aSAH patients ≥18 years old grouped by standard monitoring protocol (6–7 days, group 1) and those with longer monitoring (>7 days, group 2). Clinical characteristics, EEG features, length of stay (LOS) and functional outcome were compared using univariate analyses. Multivariable analyses tested the association between the groups and vasospasm, DCI, LOS, and modified Rankin Scale (mRS). Results 19 patients met criteria for group 1 and 16 patients for group 2. We found no difference in EEG's detection of worsening abnormal EEG activity, vasospasm and DCI. ICU and hospital LOS in group 2 were nearly double that of group 1 (ICU: 25.5 (19.5–35) vs. 14 (11–21) days, p = 0.0003; hospital: 32.5 (29.5–48) vs. 18 (13–29) days, p = 0.003). Good outcome (mRS ≤2) at discharge and at 6 months was similar in both groups (21.1% vs. 0% and 56.3% vs. 46.2%). In multivariable analysis, EEG duration was independently associated with ICU and hospital LOS but not with vasospasm, DCI, and mRS at 6 months. Conclusions Longer EEG monitoring correlated with significantly longer ICU and hospital LOS but not with vasospasm, DCI, and functional outcome at 6 months. Larger studies to confirm our findings are warranted.
No takes yet. Share an insight, caveat, or question.
Solnicky et al. (2026) conducted an observational in Aneurysmal subarachnoid hemorrhage (n=35). Extended continuous EEG monitoring (>7 days or reconnected) vs. Standard continuous EEG monitoring (6-7 days) was evaluated on Development of vasospasm (p=0.39). Extended continuous EEG monitoring beyond 7 days in patients with aneurysmal subarachnoid hemorrhage did not significantly increase the detection of vasospasm, delayed cerebral ischemia, or seizures, but was correlated with significantly longer ICU and hospital lengths of stay.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: